SQZ Biotechnologies Beheer
Beheer criteriumcontroles 2/4
SQZ Biotechnologies' CEO is Howard Bernstein, appointed in Nov 2022, has a tenure of 2.08 years. directly owns 0.2% of the company’s shares, worth $1.37K. The average tenure of the management team and the board of directors is 2.9 years and 4.1 years respectively.
Belangrijke informatie
Howard Bernstein
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 2yrs |
Eigendom CEO | 0.2% |
Management gemiddelde ambtstermijn | 2.9yrs |
Gemiddelde ambtstermijn bestuur | 4.1yrs |
Recente managementupdates
Recent updates
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%
Jun 26We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully
Jan 05SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M
Nov 09SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology
Oct 20Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?
Aug 20SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M
Aug 04SQZ Biotechnologies names business chief as CFO
Jul 11Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook
May 17Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation
May 02Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation
Jan 11Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?
Jul 30Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)
May 16Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts
Mar 25SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 20We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth
Feb 01Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$72m |
Jun 30 2023 | n/a | n/a | -US$71m |
Mar 31 2023 | n/a | n/a | -US$76m |
Dec 31 2022 | US$2m | US$400k | -US$79m |
Sep 30 2022 | n/a | n/a | -US$78m |
Jun 30 2022 | n/a | n/a | -US$78m |
Mar 31 2022 | n/a | n/a | -US$74m |
Dec 31 2021 | US$1m | US$391k | -US$69m |
Sep 30 2021 | n/a | n/a | -US$75m |
Jun 30 2021 | n/a | n/a | -US$64m |
Mar 31 2021 | n/a | n/a | -US$55m |
Dec 31 2020 | US$750k | US$357k | -US$51m |
Compensatie versus markt: Insufficient data to establish whether Howard's total compensation is reasonable compared to companies of similar size in the US market.
Compensatie versus inkomsten: Howard's compensation has increased whilst the company is unprofitable.
CEO
Howard Bernstein (67 yo)
2yrs
Tenure
US$1,624,513
Compensatie
Dr. Howard Bernstein, M.D., Ph D., had been Chief Scientific Officer of SQZ Biotechnologies Company since June 2015 until October 31, 2022. Dr. Bernstein is Director of SQZ Biotechnologies Company since Oc...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Interim CEO & Director | 2yrs | US$1.62m | 0.20% $ 1.4k | |
General Counsel & Secretary | 5.2yrs | US$944.03k | 0.0066% $ 44.6 | |
Chief Medical Officer | 2.4yrs | US$944.27k | 0% $ 0 | |
Co-Founder & Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Chief Accounting Officer | 3yrs | geen gegevens | geen gegevens | |
Chief People Officer | 4.5yrs | geen gegevens | geen gegevens | |
Senior Vice President of CMC & QUALITY | 2.8yrs | geen gegevens | geen gegevens |
2.9yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren management: SQZB's management team is considered experienced (2.9 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Interim CEO & Director | 2.1yrs | US$1.62m | 0.20% $ 1.4k | |
Co-Founder & Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Director | no data | US$104.40k | 0.74% $ 5.0k | |
Independent Director | 3.3yrs | US$96.62k | 0% $ 0 | |
Independent Director | 11.7yrs | US$89.40k | 1.15% $ 7.8k | |
Independent Chairman | 3.3yrs | US$94.40k | 0% $ 0 | |
Independent Director | 6.5yrs | US$86.90k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 6.3yrs | US$94.40k | 0% $ 0 | |
Independent Director | 4.1yrs | US$94.40k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens |
4.1yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: SQZB's board of directors are considered experienced (4.1 years average tenure).